- Home
- TIVC vs RDHL Comparison
TIVC vs RDHL Comparison
Compare TIVC & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIVC
- RDHL
- Stock Information
- Founded
- TIVC 2016
- RDHL 2009
- Country
- TIVC United States
- RDHL Israel
- Employees
- TIVC N/A
- RDHL N/A
- Industry
- TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- TIVC Health Care
- RDHL Health Care
- Exchange
- TIVC Nasdaq
- RDHL Nasdaq
- Market Cap
- TIVC 4.0M
- RDHL 4.3M
- IPO Year
- TIVC 2021
- RDHL N/A
- Fundamental
- Price
- TIVC $3.98
- RDHL $1.93
- Analyst Decision
- TIVC
- RDHL
- Analyst Count
- TIVC 0
- RDHL 0
- Target Price
- TIVC N/A
- RDHL N/A
- AVG Volume (30 Days)
- TIVC 19.5K
- RDHL 44.7K
- Earning Date
- TIVC 08-13-2025
- RDHL 08-28-2025
- Dividend Yield
- TIVC N/A
- RDHL N/A
- EPS Growth
- TIVC N/A
- RDHL N/A
- EPS
- TIVC N/A
- RDHL N/A
- Revenue
- TIVC $516,000.00
- RDHL $8,042,999.00
- Revenue This Year
- TIVC N/A
- RDHL $381.91
- Revenue Next Year
- TIVC N/A
- RDHL N/A
- P/E Ratio
- TIVC N/A
- RDHL N/A
- Revenue Growth
- TIVC N/A
- RDHL 23.17
- 52 Week Low
- TIVC $2.43
- RDHL $1.71
- 52 Week High
- TIVC $16.08
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- TIVC 52.13
- RDHL 52.90
- Support Level
- TIVC $3.87
- RDHL $1.88
- Resistance Level
- TIVC $4.08
- RDHL $2.62
- Average True Range (ATR)
- TIVC 0.23
- RDHL 0.14
- MACD
- TIVC 0.01
- RDHL 0.02
- Stochastic Oscillator
- TIVC 44.44
- RDHL 32.89
About TIVC Tivic Health Systems Inc.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.